Please login to the form below

Not currently logged in
Email:
Password:

GSK’s finance SVP joins Parexel International

Simon Harford becomes chief financial officer

Pharmaceutical services provider Parexel International has appointed Simon Harford as chief financial officer and senior vice president from 1 June.

Harford joins from GlaxoSmithKline, where he most recently served as senior vice president of finance, based at the pharma firm's global headquarters in the UK.

Prior to joining GSK in 2009, Harford served as group vice president and controller at cosmetics firm Avon, having previously spent two decades at Eli Lilly in a number of roles including chief financial officer for its EMEA operations.

Josef von Rickenbach, chairman and chief executive of Parexel, said: “Simon brings to Parexel more than three decades of global financial management and investor relations experience in the pharmaceutical industry.

“Simon's leadership will strengthen our ability to accelerate growth and improve profitability as we implement our corporate strategy.”

7th March 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Patient engagement
Taking a holistic approach to patient care
The importance of recognising each patient as an individual...
The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....

Infographics